Glaucoma

Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors

Vitamins B6, B9 and B12 were found to be neuroprotective against retinal ganglion cell death

Social determinants of health challenge our existing expectations

The novel nitric oxide-donating bimatoprost eye drop is designed to lower IOP in patients with open-angle glaucoma or ocular hypertension

Voyager DSLT is already available in select markets in the EU and the UK, and reduces the specialised training required with manual selective laser trabeculoplasty

The link between eye health and mental health may be deeper than previously believed

Our top 10 print stories highlight the core content concepts we explored this year

Gauging patient perceptions in an ethnically diverse UK cohort

A higher body mass index was protective against glaucoma progression, while patients who were underweight had significantly faster rates of structural loss

Two glaucoma specialists discuss pairing patients with the right procedures

Moving on from medication “stacks” and the old-school reactive approach

In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma

Uncertainty during everyday navigation tasks may adversely affect quality of life for patients with glaucoma

Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

Smaller surgeries, in greater numbers, await new glaucoma specialists

Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma

Management of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents

Metabolomics reflects the physiological state of a tissue and provides information about interactions between genetics, environment and lifestyle

Investigators assessed the XEN45 implant alone and in combination with phacoemulsification

Early results indicate that trained optometrists delivered safe and effective laser treatments

This year’s meeting will take place in Ireland’s technology and business hub

Three approaches to examination give a comprehensive overview

Three leaders in glaucoma research, retina care and refractive surgery share their expertise

Dr Nir Shoham-Hazon presented two papers detailing outcomes from the iTrack microcatheter at ASCRS in Boston

At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT

At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma

The glaucoma specialist talks about navigating the world of research, and the realities of motherhood, as a clinician

Proteins common to Alzheimer disease play a significant role in glaucoma

Innovative therapies scale up to meet needs of a growing patient population

The company made its CE Mark announcement during the ESCRS Winter Meeting